Table 1 Clinicopathological characteristics of 630 patients with sporadic CRC according to the number of somatic APC hits (truncating mutation and LOH)

From: Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis

Characteristic

All patients

Number of APC hits

P-value

  

0 Hits (%)

1 Hit (%)

2 Hits (%)

3 Hits (%)

Any hit (%)

0 vs any hit

3 vs 1 or 2 hits

Age, years

 Median

70

73

69

69

73

69

0.002*

0.147

 Range

30–99

31–99

30–93

33–92

50–86

30–93

  

Gender

 Male

353 (56.0)

70 (19.8)

83 (23.5)

195 (55.2)

5 (1.4)

283 (80.2)

<0.001*

0.011*

 Female

277 (44.0)

89 (32.1)

53 (19.1)

123 (44.4)

12 (4.3)

188 (67.9)

  

Location

 Proximal colon

273 (43.3)

93 (34.1)

48 (17.6)

118 (43.2)

14 (5.1)

180 (65.9)

<0.001*

0.001*

 Distal colon

198 (31.4)

34 (17.2)

47 (23.7)

115 (58.1)

2 (1.0)

164 (82.8)

  

 Rectum

159 (25.2)

32 (20.1)

41 (25.8)

85 (53.5)

1 (0.6)

127 (79.9)

  

Tumour stage

 I

60 (9.5)

12 (20.0)

11 (18.3)

36 (60.0)

1 (1.7)

48 (80.0)

0.200

0.406

 II

188 (29.8)

44 (23.4)

37 (19.7)

100 (53.2)

7 (3.7)

144 (76.6)

  

 III

296 (47.0)

86 (29.1)

68 (23.0)

137 (46.3)

5 (1.7)

210 (70.9)

  

 IV

86 (13.7)

17 (19.8)

20 (23.3)

45 (52.3)

4 (4.7)

69 (80.2)

  

Differentiation

 Well/moderate

458 (76.0)

97 (21.2)

99 (21.6)

249 (54.4)

13 (2.8)

361 (78.8)

0.001*

0.760

 Poor

145 (24.0)

52 (35.9)

28 (19.3)

61 (42.1)

4 (2.8)

93 (64.1)

  

 Unknown

27

10

9

8

0

17

  

Lymphovascular invasion

 Absent

215 (63.2)

44 (20.5)

36 (16.7)

124 (57.7)

11 (5.1)

171 (79.5)

0.890

0.583

 Present

125 (36.8)

27 (21.6)

25 (20.0)

69 (55.2)

4 (3.2)

98 (78.4)

  

 Unknown

290

88

75

125

2

202

  

Mucinous histology

 No

397 (79.1)

80 (20.2)

88 (22.2)

217 (54.7)

12 (3.0)

317 (79.8)

0.001*

0.192

 Yes

105 (20.9)

38 (36.2)

16 (15.2)

46 (43.8)

5 (4.8)

67 (63.8)

  

 Unknown

128

41

32

55

0

87

  

MSI status

 MSS

540 (85.7)

99 (18.3)

127 (23.5)

302 (55.9)

12 (2.2)

441 (81.7)

<0.001*

0.003*

 MSI

90 (14.3)

60 (66.7)

9 (10.0)

16 (17.8)

5 (5.6)

30 (33.3)

  
  1. Abbreviations: CRC, colorectal cancer; LOH, loss of heterozygosity; MSI, microsatellite unstable; MSS, microsatellite stable.
  2. *P<0.05.